ILC seeks £4m to help advance COVID-19 trials
The two treatments could ‘constitute an early stage and late stage treatment option for all COVID-19 patients’
Read More
Tag: Interferon Alpha 14
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
